Associated Papers
Familial mast cell-mediated angioedema: Description of 4 families.
Sabaté-Brescó M et al.
The Journal of Allergy and Clinical Immunology. in Practice, 2025
The CD28 IVS3 + 17 T/C polymorphism and the GVHD occurrence in Tunisian patients receiving an HLA-identical sibling HSCs transplant.
Ghazouani E et al.
Human Immunology, 2024
HLA-DRB1, IRF5, and CD28 gene polymorphisms in Egyptian patients with rheumatoid arthritis: susceptibility and disease activity.
Said NM et al.
Genes and Immunity, 2021
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case-control study in eastern Chinese population.
Yang J et al.
Bioscience Reports, 2019
Association Between the CD28 c.17 +3 T>C Polymorphism (rs3116496) and Cancer Risk: An Updated Meta-Analysis.
Zeng Y et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2019
Co-stimulatory CD28 and transcription factor NFKB1 gene variants affect idiopathic recurrent miscarriages.
Misra MK et al.
Journal of Human Genetics, 2016
Association between IVS3 +17T/C CD28 gene polymorphism and the acute kidney allograft rejection.
Pawlik A et al.
Transplant Immunology, 2014
The Interaction Between Allelic Variants of CD86 and CD40LG: A Common Risk Factor of Allergic Asthma and Rheumatoid Arthritis.
Lee SH et al.
Allergy, Asthma & Immunology Research, 2014
CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura.
Wang JJ et al.
Pediatric Nephrology (berlin, Germany), 2012
[Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer].
Li H et al.
Zhonghua Zhong Liu Za Zhi [chinese Journal of Oncology], 2011
Association of CD28 gene polymorphism with cervical cancer risk in a Chinese population.
Chen X et al.
International Journal of Immunogenetics, 2011
Association of CD28 IVS3 +17T/C polymorphism with soluble CD28 in rheumatoid arthritis.
Ledezma-Lozano IY et al.
Disease Markers, 2011
Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma.
Kämmerer PW et al.
Oral Oncology, 2010
The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients.
Kusztal M et al.
Transplant Immunology, 2010
Investigation of CTLA-4 and CD28 gene polymorphisms in patients with diabetes mellitus type 2 using PCR-RFLP in a Turkish population.
Uzer E et al.
The West Indian Medical Journal, 2010
The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population.
Wang JJ et al.
International Journal of Immunogenetics, 2009
Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer.
Dilmec F et al.
International Journal of Immunogenetics, 2008
Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease.
Gunesacar R et al.
International Journal of Immunogenetics, 2007
Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K et al.
Immunogenetics, 2001
Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population.
Ahmed S et al.
Rheumatology (oxford, England), 2001
Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese population.
Nakao F et al.
Experimental and Clinical Immunogenetics, 2000